News

Sickle cell disease—the subject of a new Seminar in The Lancet—is one of the most prevalent and fastest-growing genetic disorders worldwide. Although its true…

Advanced genomic technologies are revolutionizing our ability to understand complex diseases. Large‐scale population studies are needed to realize the potential of…

The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics, pH and food effect, and preliminary efficacy of BMS-…

The American Society of Gene and Cell Therapy is hosting this free virtual summit that will bring together patients, caregivers, advocates, researchers, and…

In the U.S., having sickle cell disease (SCD) continues to place a heavy clinical burden on patients, who often require multiple medications, frequent blood…

A woman whose blood donations are so rare they are frozen for up to 30 years said she feels "very special and honoured" to be able to help sick patients.Mina…

Health workers in Iganga district have raised alarm over what theydescribed as worrying cases of sickle cell disease, disclosing thatbetween 5 and 10 new cases are…

KEY MARKET INSIGHTSListen to Audio VersionThe global sickle cell disease treatment market size was estimated at USD 3.94 billion in 2025 and is projected to reach…

Summary: Sickle cell disease (SCD) is widely recognized as a blood disorder, but new research reveals its profound impact on the brain’s architecture. Using…

Nigerians have taken to social media to mourn the death of first class graduate and  sickle cell advocate Anisa Ishaq-Balogun, whose passing has triggered an…